Quantifying the number of lymph nodes for examination in breast cancer

Objective Examining the correct number of lymph nodes when diagnosing breast cancer invasion is still a problem. This work aimed to develop a qualification model that estimates the possibility of missing nodes and the number of lymph nodes that need to be examined. Methods By analyzing lymph node in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2020-02, Vol.48 (2), p.300060519879594-300060519879594
Main Authors: Sun, Liping, Li, Ping, Ren, He, Liu, Gang, Sun, Lining
Format: Article
Language:English
Subjects:
Breast cancer
Breast Neoplasms - diagnosis
Humans
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Lymphatic system
Models, Statistical
Neoplasm Staging
Retrospective Clinical Research Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Examining the correct number of lymph nodes when diagnosing breast cancer invasion is still a problem. This work aimed to develop a qualification model that estimates the possibility of missing nodes and the number of lymph nodes that need to be examined. Methods By analyzing lymph node invasion of 303,760 breast cancer samples with primary tumor stage and the number of examined and positive lymph nodes from the Surveillance, Epidemiology and End Results database using a beta-binomial model, the number of nodes that should be examined was quantified in different stages. Results In general, to reduce the possibility of missing positive nodes to less than 10%, 21 lymph nodes should be examined; thus, the current median of dissected nodes (12) is not adequate. The number of nodes needed to be dissected for stages T1, T2, and T3 are 8, 37, and 87, respectively. Currently, the median number of node dissections for these stages were 12, 13, and 14, respectively. The clinical significance of the nodal staging score was validated with survival information. Conclusion Currently, the number of lymph nodes dissected in breast cancer are excessive for T1 but insufficient for T2 and T3.
ISSN:0300-0605
1473-2300
DOI:10.1177/0300060519879594